Repro Med Systems (KRMD) reported Q4 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.38 million.
GUIDANCE:
Repro Med Systems sees FY2023 revenue of $32.5-33.5 million, versus the consensus of $30.914 million.